Jasper Therapeutics Capital Expenditures (CapEx) Growth & History (JSPR)
Jasper Therapeutics's capital expenditures (capex) was $7,000 for fiscal 2025.
View full Jasper Therapeutics company overviewJasper Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $7,000 | −$545,000 | −98.73% |
| 2024 | 2024-12-31 | $552,000 | $285,000 | +106.74% |
| 2023 | 2023-12-31 | $267,000 | −$309,000 | −53.65% |
| 2022 | 2022-12-31 | $576,000 | −$1.9M | −76.28% |
| 2021 | 2021-12-31 | $2.4M | — | — |
Jasper Therapeutics quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q3 2025 | 2025-09-30 | $0 | −$274,000 | — |
| Q4 2024 | 2024-12-31 | $96,000 | −$134,000 | −58.26% |
| Q3 2024 | 2024-09-30 | $274,000 | $274,000 | — |
| Q2 2024 | 2024-06-30 | $157,000 | $146,000 | +1327.27% |
| Q1 2024 | 2024-03-31 | $25,000 | −$1,000 | −3.85% |
| Q4 2023 | 2023-12-31 | $230,000 | $148,000 | +180.49% |
| Q3 2023 | 2023-09-30 | $0 | −$222,000 | — |
| Q2 2023 | 2023-06-30 | $11,000 | −$232,000 | −95.47% |
| Q1 2023 | 2023-03-31 | $26,000 | −$3,000 | −10.34% |
| Q4 2022 | 2022-12-31 | $82,000 | −$629,000 | −88.47% |
| Q3 2022 | 2022-09-30 | $222,000 | −$248,000 | −52.77% |
| Q2 2022 | 2022-06-30 | $243,000 | −$44,000 | −15.33% |
| Q1 2022 | 2022-03-31 | $29,000 | −$931,000 | −96.98% |
| Q4 2021 | 2021-12-31 | $711,000 | — | — |
| Q3 2021 | 2021-09-30 | $470,000 | — | — |
| Q2 2021 | 2021-06-30 | $287,000 | — | — |
| Q1 2021 | 2021-03-31 | $960,000 | — | — |
Jasper Therapeutics capital expenditures (capex) trends
Between the periods ended 2021-12-31 and 2025-12-31, Jasper Therapeutics's capital expenditures (capex) decreased from $2.4M to $7,000, a change of −$2.4M. The latest reported quarter, Q3 2025, shows $0.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Jasper Therapeutics source filings ↗